We are aware of phishing emails targeting speakers of events whose names appear on our events pages. If you are unsure if an email regarding event registration or accommodation has come from us please contact us and do not provide any credit card details or personal information
12 May 2016 07:30 - 13 May 2016 18:30, London, United Kingdom
Introduction
In keeping with Oxford Global’s highly successful life sciences series, an expert panel of over 30 speakers will present a full conference programme covering the topics outlined below.
Advances in Immuno-oncology Congress
Day 1 Stream 1 – Discovery and Early Development of Immuno-oncology Therapies
Key therapeutic strategies in immuno-oncology
– Checkpoint inhibitors
– CAR T cell therapies
– Adoptive cell transfer
– Cancer vaccines & oncolytic viral therapies
– Immune receptor agonist antibodies
– BiTe (Bispecific T Cell Engagers)
Targeting the PD-1 pathway and finding alternative therapeutic targets
Novel technologies to enhance discovery of immunotherapies in oncology
Molecular oncology updates including B cells
Day 1 Stream 2 – Immuno-Oncology: Therapeutic Approaches, Clinical Research and Clinical Trials
Approaches to clinical trial design & development
Key safety challenges in cancer immunotherapy clinical trials
Strategies for effective trial management
Clinical data & case studies
Clinical immuno-oncology combinations in different cancers and tumour types
Establishing partnerships and collaborations
Biomarkers in immuno-oncology
Clinical diagnostics & the potential of NGS in immuno-oncology clinical trials
Day 2– Preclinical Development, Assays and Modelling in Immuno-oncology
Preclinical models including humanised mouse models
Preclinical assay development
Translational strategies
Approaches to preclinical combination therapy design
Reducing toxicity challenges in immuno-oncology therapeutics
